BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32002306)

  • 21. Association of increased eomesodermin, BCL6, and granzyme B expression with major clinical manifestations of Hashimoto's thyroiditis - an observational study.
    Štefanić M; Tokić S; Suver Stević M; Glavaš-Obrovac L
    Immunol Invest; 2018 Apr; 47(3):279-292. PubMed ID: 29319368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF.
    Podaza E; Carri I; Aris M; von Euw E; Bravo AI; Blanco P; Ortiz Wilczyñski JM; Koile D; Yankilevich P; Nielsen M; Mordoh J; Barrio MM
    Front Immunol; 2020; 11():1147. PubMed ID: 32582212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.
    Walker SR; Nelson EA; Frank DA
    Oncogene; 2007 Jan; 26(2):224-33. PubMed ID: 16819511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
    León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
    Front Immunol; 2020; 11():583382. PubMed ID: 33240271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL
    Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients.
    Gannon PO; Baumgaertner P; Huber A; Iancu EM; Cagnon L; Abed Maillard S; Maby-El Hajjami H; Speiser DE; Rufer N
    Clin Cancer Res; 2017 Jul; 23(13):3285-3296. PubMed ID: 27872103
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
    Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
    Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional repressor BCL6 controls Th17 responses by controlling gene expression in both T cells and macrophages.
    Mondal A; Sawant D; Dent AL
    J Immunol; 2010 Apr; 184(8):4123-32. PubMed ID: 20212093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
    Toida N; Hajishengallis G; Wu HY; Russell MW
    Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma vaccines: the paradox of T cell activation without clinical response.
    Nielsen MB; Marincola FM
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S62-6. PubMed ID: 10950150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergic T
    Ogasawara T; Kohashi Y; Ikari J; Taniguchi T; Tsuruoka N; Watanabe-Takano H; Fujimura L; Sakamoto A; Hatano M; Hirata H; Fukushima Y; Fukuda T; Kurasawa K; Tatsumi K; Tokuhisa T; Arima M
    Front Immunol; 2018; 9():750. PubMed ID: 29696026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a Murine Tumor Rejection Model.
    Gąbka-Buszek A; Kwiatkowska-Borowczyk E; Jankowski J; Kozłowska AK; Mackiewicz A
    Vaccines (Basel); 2020 Mar; 8(2):. PubMed ID: 32224883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.
    Tjin EP; Krebbers G; Meijlink KJ; van de Kasteele W; Rosenberg EH; Sanders J; Nederlof PM; van de Wiel BA; Haanen JB; Melief CJ; Vyth-Dreese FA; Luiten RM
    Cancer Immunol Res; 2014 Jun; 2(6):538-46. PubMed ID: 24894091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-γ and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection.
    Carpio VH; Opata MM; Montañez ME; Banerjee PP; Dent AL; Stephens R
    PLoS One; 2015; 10(12):e0144654. PubMed ID: 26646149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation.
    Liu X; Lu H; Chen T; Nallaparaju KC; Yan X; Tanaka S; Ichiyama K; Zhang X; Zhang L; Wen X; Tian Q; Bian XW; Jin W; Wei L; Dong C
    Cell Rep; 2016 Feb; 14(7):1735-1747. PubMed ID: 26876184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
    Kayaga J; Souberbielle BE; Sheikh N; Morrow WJ; Scott-Taylor T; Vile R; Chong H; Dalgleish AG
    Gene Ther; 1999 Aug; 6(8):1475-81. PubMed ID: 10467372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of augmented anti-tumor immunity in reconstituted lymphopenic mice immunized with melanoma vaccine].
    Ma J; Wang YL; Hu HM; Fox BA; Si LS
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):708-12. PubMed ID: 16483476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plastic downregulation of the transcriptional repressor BCL6 during maturation of human dendritic cells.
    Pantano S; Jarrossay D; Saccani S; Bosisio D; Natoli G
    Exp Cell Res; 2006 May; 312(8):1312-22. PubMed ID: 16455075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Id3 and Bcl6 Promote the Development of Long-Term Immune Memory Induced by Tuberculosis Subunit Vaccine.
    Han J; Ma Y; Ma L; Tan D; Niu H; Bai C; Mi Y; Xie T; Lv W; Wang J; Zhu B
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33562631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
    Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
    Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.